No Photo Available

Last Update

2016-05-10T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong Doug Plessinger?

Mr. Doug Plessinger

Vice President, Medical and Clinical Affairs

Aprecia Pharmaceuticals Company

Direct Phone: (513) ***-****       

Email: d***@***.com

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Aprecia Pharmaceuticals Company

2010 West Cabot Boulevard

Langhorne, Pennsylvania 19043

United States

Company Description

Aprecia is a commercial stage pharmaceutical company developing, manufacturing and marketing fast melt formulations of high dose pharmaceuticals, initially focused on epilepsy and other central nervous system disorders. Aprecia manufactures its products u ... more

Find other employees at this company (99)

Background Information

Employment History

Vice President of Clinical and Medical Affairs

Argos Therapeutics , Inc.

Senior Vice President, Account Services

The Navicor Group LLC

Position, Medical Affairs

Bristol-Myers Squibb Company

Executive Vice President and Managing Director

Axcelo MSL Solutions, LLC

Founding Partner, Managing Director

venn5 BioConsulting LLC

Affiliations

Medical Science Liaison
Millennium Pharmaceuticals , Inc.

Education

B.S.

pharmacy

Northeastern University

Web References (19 Total References)


Argos Therapeutics Announces Completion of Patient Enrollment in Pivotal Phase 3 ADAPT Clinical Trial of AGS-003 - TVM Capital Life Science Venture Capital

www.tvm-lifescience.com [cached]

"The ADAPT trial is focused on a population with significant unmet needs as the expected median survival based upon International mRCC Database Consortium (IMDC) benchmarks is approximately 15 months after diagnosis, even with standard surgery and approved targeted therapies," said Doug Plessinger, vice president of clinical and medical affairs for Argos Therapeutics.


...

www.sec.gov [cached]

0001542968 Plessinger Douglas C. 4233 TECHNOLOGY DRIVE DURHAM NC 27704 0 1 0 0 See Remarks


Actinium's Chief Medical Officer to Participate in the Next Gen Immunotherapeutics Panel at the 3rd Annual Sachs Cancer Bio Partnering & Investment Forum on February 23rd :: Actinium Pharmaceuticals, Inc. (ATNM)

ir.actiniumpharma.com [cached]

Doug Plessinger, VP, Clinical and Medical Affair, Argos Therapeutics, Inc.


Management – Argos Therapeutics

ir.argostherapeutics.com [cached]

Douglas Plessinger RPh Vice President, Clinical and Medical Affairs Douglas C. Plessinger, RPh, joined as our Vice President of Clinical and Medical Affairs effective October 2011, after serving as a clinical consultant for Argos since October 2007. Prior to joining us, Mr. Plessinger served as Executive Vice President and Managing Director at Axcelo MSL Solutions, LLC, an oncology consulting company, from August 2008 to September 2011 and founding partner and Managing Director of its predecessor company, venn5 BioConsulting, LLC, from 2007 to 2008. Prior to this, he served as Senior Vice President, Account Services at The Navicor Group, LLC, a healthcare advertising agency and a division of inVentiv Health, Inc., a healthcare services company, from 2004 to 2007; Oncology Medical Science Liaison at Millennium Pharmaceuticals, Inc., from 2002 to 2003; and in various Medical Affairs and Product Development roles at Bristol-Myers Squibb Oncology, a pharmaceutical company, from 1997 to 2002. Mr. Plessinger received a B.S. in pharmacy from Northeastern University.


Argos Therapeutics – Leadership

www.argostherapeutics.com [cached]

Doug Plessinger, RPh Vice President, Clinical and Medical Affairs Douglas C. Plessinger, RPh, joined as our Vice President of Clinical and Medical Affairs effective October 2011, after serving as a clinical consultant for Argos since October 2007. Prior to joining us, Mr. Plessinger served as Executive Vice President and Managing Director at Axcelo MSL Solutions, LLC, an oncology consulting company, from August 2008 to September 2011 and founding partner and Managing Director of its predecessor company, venn5 BioConsulting, LLC, from 2007 to 2008. Prior to this, he served as Senior Vice President, Account Services at The Navicor Group, LLC, a healthcare advertising agency and a division of inVentiv Health, Inc., a healthcare services company, from 2004 to 2007; Oncology Medical Science Liaison at Millennium Pharmaceuticals, Inc., from 2002 to 2003; and in various Medical Affairs and Product Development roles at Bristol-Myers Squibb Oncology, a pharmaceutical company, from 1997 to 2002. Mr. Plessinger received a B.S. in pharmacy from Northeastern University.

Similar Profiles

Other People with this Name

Other people with the name Plessinger

Marcia Plessinger
University of North Carolina

Jennifer Plessinger
The Walt Disney Company

Michele Plessinger
Gilman Partners LLC

Melody Plessinger
IBM Corporation

Aaron Plessinger
100%

City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory